{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T12:21:40Z","timestamp":1783081300833,"version":"3.54.6"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81873759"],"award-info":[{"award-number":["81873759"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.intimp.2020.107092","type":"journal-article","created":{"date-parts":[[2020,12,4]],"date-time":"2020-12-04T23:54:46Z","timestamp":1607126086000},"page":"107092","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["Nicotinamide adenine dinucleotide treatment alleviates the symptoms of experimental autoimmune encephalomyelitis by activating autophagy and inhibiting the NLRP3 inflammasome"],"prefix":"10.1016","volume":"90","author":[{"given":"Xin","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianzhao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.intimp.2020.107092_b0005","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/nrneurol.2015.222","article-title":"Synaptopathy connects inflammation and neurodegeneration in multiple sclerosis","volume":"11","author":"Mandolesi","year":"2015","journal-title":"Nature Rev. Neurol."},{"key":"10.1016\/j.intimp.2020.107092_b0010","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.3389\/fimmu.2019.02578","article-title":"OLT1177 (Dapansutrile), a Selective NLRP3 Inflammasome Inhibitor, Ameliorates Experimental Autoimmune Encephalomyelitis Pathogenesis","volume":"10","author":"Sanchez-Fernandez","year":"2019","journal-title":"Front Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2020.107092_b0015","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1089\/ars.2007.1672","article-title":"NAD(+)\/ NADH and NADP(+)\/NADPH in cellular functions and cell death: Regulation and biological consequences","volume":"10","author":"Ying","year":"2008","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.intimp.2020.107092_b0020","article-title":"Oxidative stress and non-SOD1 ALS","volume":"9","author":"Carri","year":"2015","journal-title":"Front Cell Neurosci."},{"issue":"12","key":"10.1016\/j.intimp.2020.107092_b0025","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1002\/glia.20440","article-title":"Hypoglycemia, brain energetics, and hypoglycemic neuronal death","volume":"55","author":"Suh","year":"2007","journal-title":"Glia"},{"key":"10.1016\/j.intimp.2020.107092_b0030","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.intimp.2016.07.036","article-title":"Treatment with NAD(+) inhibited experimental autoimmune encephalomyelitis by activating AMPK\/SIRT1 signaling pathway and modulating Th1\/Th17 immune responses in mice","volume":"39","author":"Wang","year":"2016","journal-title":"Int. Immunopharmacol."},{"issue":"5","key":"10.1016\/j.intimp.2020.107092_b0035","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.neuron.2017.01.022","article-title":"Autophagy and Neurodegeneration: Pathogenic Mechanisms and Therapeutic Opportunities","volume":"93","author":"Menzies","year":"2017","journal-title":"Neuron"},{"issue":"9","key":"10.1016\/j.intimp.2020.107092_b0040","doi-asserted-by":"crossref","first-page":"985","DOI":"10.4161\/auto.7.9.16012","article-title":"In vivo optical imaging of motor neuron autophagy in a mouse model of amyotrophic lateral sclerosis","volume":"7","author":"Tian","year":"2011","journal-title":"Autophagy"},{"issue":"1","key":"10.1016\/j.intimp.2020.107092_b0045","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.coi.2011.10.006","article-title":"Autophagy as an innate immunity paradigm: expanding the scope and repertoire of pattern recognition receptors","volume":"24","author":"Deretic","year":"2012","journal-title":"Curr. Opin. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2020.107092_b0050","first-page":"95","article-title":"Defective autophagy is associated with neuronal injury in a mouse model of multiple sclerosis","volume":"17","author":"Feng","year":"2017","journal-title":"Bosnian J. Basic Med. Sci."},{"key":"10.1016\/j.intimp.2020.107092_b0055","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.4049\/jimmunol.170.4.2153","article-title":"Induction of experimental autoimmune encephalomyelitis in IL-12 receptor-\u03b22-deficient mice: IL-12 responsiveness is not required in the pathogenesis of inflammatory demyelination in the central nervous system","volume":"170","author":"Zhang","year":"2003","journal-title":"J Immunol."},{"key":"10.1016\/j.intimp.2020.107092_b0060","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1093\/brain\/awx113","article-title":"Loss of 'homeostatic' microglia and patterns of their activation in active multiple sclerosis","volume":"140","author":"Zrzavy","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.intimp.2020.107092_b0065","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.mce.2016.11.003","article-title":"NAD and the aging process: Role in life, death and everything in between","volume":"455","author":"Chini","year":"2017","journal-title":"Mol. Cell Endocrinol."},{"issue":"3","key":"10.1016\/j.intimp.2020.107092_b0070","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.cmet.2017.11.002","article-title":"NAD(+) Intermediates: The Biology and Therapeutic Potential of NMN and NR","volume":"27","author":"Yoshino","year":"2018","journal-title":"Cell Metab."},{"issue":"42","key":"10.1016\/j.intimp.2020.107092_b0075","doi-asserted-by":"crossref","first-page":"10654","DOI":"10.1073\/pnas.1809392115","article-title":"Pharmacological bypass of NAD(+) salvage pathway protects neurons from chemotherapy-induced degeneration","volume":"115","author":"Liu","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"issue":"9","key":"10.1016\/j.intimp.2020.107092_b0080","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1038\/s41591-018-0138-z","article-title":"De novo NAD(+) biosynthetic impairment in acute kidney injury in humans","volume":"24","author":"Mehr","year":"2018","journal-title":"Nat Med."},{"key":"10.1016\/j.intimp.2020.107092_b0085","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.dnarep.2014.07.009","article-title":"Regulation of NAD plus metabolism, signaling and compartmentalization in the yeast Saccharomyces cerevisiae","volume":"23","author":"Kato","year":"2014","journal-title":"DNA Repair"},{"issue":"9","key":"10.1016\/j.intimp.2020.107092_b0090","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1093\/hmg\/ddt016","article-title":"NAD(+) salvage pathway proteins suppress proteotoxicity in yeast models of neurodegeneration by promoting the clearance of misfolded\/oligomerized proteins","volume":"22","author":"Ocampo","year":"2013","journal-title":"Hum. Mol. Genet."},{"issue":"9","key":"10.1016\/j.intimp.2020.107092_b0095","doi-asserted-by":"crossref","first-page":"4478","DOI":"10.4049\/jimmunol.1203172","article-title":"Cutting edge: the pathogenicity of IFN-gamma-producing Th17 cells is independent of T-bet","volume":"190","author":"Duhen","year":"2013","journal-title":"J. Immunol."},{"issue":"8","key":"10.1016\/j.intimp.2020.107092_b0100","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/nrd3800","article-title":"Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases","volume":"11","author":"Dinarello","year":"2012","journal-title":"Nat. Rev. Drug Discovery"},{"issue":"1\u20132","key":"10.1016\/j.intimp.2020.107092_b0105","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jns.2014.05.013","article-title":"The analysis of correlation between IL-1B gene expression and genotyping in multiple sclerosis patients","volume":"343","author":"Heidary","year":"2014","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.intimp.2020.107092_b0110","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1750-1326-9-56","article-title":"Interleukin-1\u03b2 causes excitotoxic neurodegeneration and multiple sclerosis disease progression by activating the apoptotic protein p53","volume":"9","author":"Rossi","year":"2014","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.intimp.2020.107092_b0115","unstructured":"N.a.J. Sandra J. Hewett, And Robert J. Claycomb. Interleukin-1\u03b2 in Central Nervous System Injury and Repair, Eur J Neurodegener Dis. 1 (2012) 195-211."},{"issue":"8","key":"10.1016\/j.intimp.2020.107092_b0120","doi-asserted-by":"crossref","first-page":"5574","DOI":"10.4049\/jimmunol.177.8.5574","article-title":"IL-1\u03b2 regulates blood-brain barrier permeability via reactivation of the hypoxia-angiogenesis program","volume":"177","author":"Argaw","year":"2006","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2020.107092_b0125","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s00281-013-0382-8","article-title":"Microglia and macrophages of the central nervous system: the contribution of microglia priming and systemic inflammation to chronic neurodegeneration","volume":"35","author":"Perry","year":"2013","journal-title":"Semin. Immunopathol."},{"issue":"17","key":"10.1016\/j.intimp.2020.107092_b0130","doi-asserted-by":"crossref","first-page":"14963","DOI":"10.1074\/jbc.M111.218867","article-title":"Marked Induction of c-Maf Protein during Th17 Cell Differentiation and Its Implication in Memory Th Cell Development","volume":"286","author":"Sato","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.intimp.2020.107092_b0135","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/ni.1917","article-title":"Complement regulator CD46 temporally regulates cytokine production by conventional and unconventional T cells","volume":"11","author":"Cardone","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.intimp.2020.107092_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2019.04.003","article-title":"Microglia: Lifelong patrolling immune cells of the brain","volume":"179","author":"Eyo","year":"2019","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.intimp.2020.107092_b0145","article-title":"Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis","volume":"10","author":"Wang","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"11","key":"10.1016\/j.intimp.2020.107092_b0150","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1038\/nn1988","article-title":"Glial cells as intrinsic components of non-cell-autonomous neurodegenerative disease","volume":"10","author":"Lobsiger","year":"2007","journal-title":"Nat. Neurosci."},{"issue":"2","key":"10.1016\/j.intimp.2020.107092_b0155","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S1097-2765(02)00599-3","article-title":"The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta","volume":"10","author":"Martinon","year":"2002","journal-title":"Mol Cell."},{"issue":"4","key":"10.1016\/j.intimp.2020.107092_b0160","doi-asserted-by":"crossref","first-page":"e109","DOI":"10.1212\/NXI.0000000000000109","article-title":"Expanding spectrum of neurologic manifestations in patients with NLRP3 low-penetrance mutations","volume":"2","author":"Schuh","year":"2015","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"10","key":"10.1016\/j.intimp.2020.107092_b0165","doi-asserted-by":"crossref","first-page":"5738","DOI":"10.4049\/jimmunol.1003597","article-title":"Caspase-1-Processed Cytokines IL-1 beta and IL-18 Promote IL-17 Production by gamma delta and CD4 T Cells That Mediate Autoimmunity","volume":"186","author":"Lalor","year":"2011","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2020.107092_b0170","doi-asserted-by":"crossref","first-page":"974","DOI":"10.4049\/jimmunol.0904145","article-title":"NLRP3 Plays a Critical Role in the Development of Experimental Autoimmune Encephalomyelitis by Mediating Th1 and Th17 Responses","volume":"185","author":"Gris","year":"2010","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2020.107092_b0175","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41580-018-0003-4","article-title":"Mechanism and medical implications of mammalian autophagy","volume":"19","author":"Dikic","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.intimp.2020.107092_b0180","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1146\/annurev-pharmtox-011112-140210","article-title":"Autophagy in toxicology: cause or consequence?","volume":"53","author":"Sten Orrenius","year":"2013","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.intimp.2020.107092_b0185","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.clim.2017.01.007","article-title":"Autophagy and autoimmunity : pathogenic mechanisms and therapeutic opportunities","volume":"176","author":"Wu","year":"2017","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.intimp.2020.107092_b0190","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.redox.2015.01.003","article-title":"Teaching the basics of autophagy and mitophagy to redox biologists-Mechanisms and experimental approaches","volume":"4","author":"Zhang","year":"2015","journal-title":"Redox Biol."},{"issue":"49","key":"10.1016\/j.intimp.2020.107092_b0195","doi-asserted-by":"crossref","first-page":"20842","DOI":"10.1073\/pnas.0911267106","article-title":"Atg9a controls dsDNA-driven dynamic translocation of STING and the innate immune response","volume":"106","author":"Saitoh","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"issue":"34","key":"10.1016\/j.intimp.2020.107092_b0200","doi-asserted-by":"crossref","first-page":"11388","DOI":"10.1523\/JNEUROSCI.1356-10.2010","article-title":"Rapamycin Activates Autophagy and Improves Myelination in Explant Cultures from Neuropathic Mice","volume":"30","author":"Rangaraju","year":"2010","journal-title":"J. Neurosci."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576920327648?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576920327648?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T04:27:57Z","timestamp":1744950477000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576920327648"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":40,"alternative-id":["S1567576920327648"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2020.107092","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nicotinamide adenine dinucleotide treatment alleviates the symptoms of experimental autoimmune encephalomyelitis by activating autophagy and inhibiting the NLRP3 inflammasome","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2020.107092","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107092"}}